EMA — authorised 16 January 2009
- Marketing authorisation holder: Chugai Pharmaceutical Co., Ltd
- Status: approved
🇪🇺 Roactemra in European Union
EMA authorised Roactemra on 16 January 2009
Marketing authorisation
Roactemra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Roactemra approved in European Union?
Yes. EMA authorised it on 16 January 2009.
Who is the marketing authorisation holder for Roactemra in European Union?
Chugai Pharmaceutical Co., Ltd holds the EU marketing authorisation.